| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 2.69e-08 | 18 | 103 | 5 | GO:0008569 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.96e-07 | 28 | 103 | 5 | GO:0051959 | |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 1.27e-06 | 37 | 103 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 3.07e-05 | 70 | 103 | 5 | GO:0003777 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase (NADPH) activity | 2.61e-04 | 5 | 103 | 2 | GO:0052851 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase activity | 2.61e-04 | 5 | 103 | 2 | GO:0000293 | |
| GeneOntologyMolecularFunction | cupric reductase (NADH) activity | 2.61e-04 | 5 | 103 | 2 | GO:0008823 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.65e-04 | 118 | 103 | 5 | GO:0003774 | |
| GeneOntologyMolecularFunction | poly(A) binding | 4.42e-04 | 29 | 103 | 3 | GO:0008143 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor | 5.44e-04 | 7 | 103 | 2 | GO:0016723 | |
| GeneOntologyMolecularFunction | poly(U) RNA binding | 7.10e-04 | 34 | 103 | 3 | GO:0008266 | |
| GeneOntologyMolecularFunction | poly-purine tract binding | 9.12e-04 | 37 | 103 | 3 | GO:0070717 | |
| GeneOntologyMolecularFunction | poly-pyrimidine tract binding | 1.06e-03 | 39 | 103 | 3 | GO:0008187 | |
| GeneOntologyCellularComponent | dynein complex | 7.21e-06 | 54 | 104 | 5 | GO:0030286 | |
| GeneOntologyCellularComponent | inner dynein arm | 1.40e-05 | 10 | 104 | 3 | GO:0036156 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.55e-04 | 161 | 104 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 1.87e-04 | 317 | 104 | 8 | GO:0032838 | |
| GeneOntologyCellularComponent | axonemal dynein complex | 2.54e-04 | 25 | 104 | 3 | GO:0005858 | |
| GeneOntologyCellularComponent | mCRD-mediated mRNA stability complex | 3.63e-04 | 6 | 104 | 2 | GO:0106002 | |
| GeneOntologyCellularComponent | axon cytoplasm | 3.69e-04 | 68 | 104 | 4 | GO:1904115 | |
| GeneOntologyCellularComponent | cytoplasmic region | 4.39e-04 | 360 | 104 | 8 | GO:0099568 | |
| GeneOntologyCellularComponent | cell leading edge | MPP2 CDC42BPA CDC42BPB PABPC1 ABLIM1 DST PABPC3 ADAM17 RASGRP2 | 8.78e-04 | 500 | 104 | 9 | GO:0031252 |
| MousePheno | enhanced leukocyte tethering or rolling | 1.90e-05 | 9 | 87 | 3 | MP:0020333 | |
| Domain | Dynein_heavy_chain_D4_dom | 7.66e-09 | 14 | 100 | 5 | IPR024317 | |
| Domain | Dynein_HC_stalk | 7.66e-09 | 14 | 100 | 5 | IPR024743 | |
| Domain | Dynein_heavy_dom-2 | 7.66e-09 | 14 | 100 | 5 | IPR013602 | |
| Domain | DHC_N2 | 7.66e-09 | 14 | 100 | 5 | PF08393 | |
| Domain | ATPase_dyneun-rel_AAA | 7.66e-09 | 14 | 100 | 5 | IPR011704 | |
| Domain | MT | 7.66e-09 | 14 | 100 | 5 | PF12777 | |
| Domain | AAA_8 | 7.66e-09 | 14 | 100 | 5 | PF12780 | |
| Domain | AAA_5 | 7.66e-09 | 14 | 100 | 5 | PF07728 | |
| Domain | DHC_fam | 1.14e-08 | 15 | 100 | 5 | IPR026983 | |
| Domain | Dynein_heavy | 1.14e-08 | 15 | 100 | 5 | PF03028 | |
| Domain | Dynein_heavy_dom | 1.14e-08 | 15 | 100 | 5 | IPR004273 | |
| Domain | PolyA | 1.48e-06 | 5 | 100 | 3 | SM00517 | |
| Domain | - | 1.48e-06 | 5 | 100 | 3 | 1.10.1900.10 | |
| Domain | PABP | 1.48e-06 | 5 | 100 | 3 | PF00658 | |
| Domain | PABP_1234 | 1.48e-06 | 5 | 100 | 3 | IPR006515 | |
| Domain | PABC | 1.48e-06 | 5 | 100 | 3 | PS51309 | |
| Domain | PABP_HYD | 1.48e-06 | 5 | 100 | 3 | IPR002004 | |
| Domain | KELK | 2.84e-05 | 2 | 100 | 2 | IPR031597 | |
| Domain | KELK | 2.84e-05 | 2 | 100 | 2 | PF15796 | |
| Domain | Myotonic_dystrophy_kinase_coil | 1.69e-04 | 4 | 100 | 2 | IPR014930 | |
| Domain | Myotonic_dystrophy_kinase_coil | 1.69e-04 | 4 | 100 | 2 | PD011252 | |
| Domain | DMPK_coil | 1.69e-04 | 4 | 100 | 2 | PF08826 | |
| Domain | RRM_1 | 2.44e-04 | 23 | 100 | 3 | SM00361 | |
| Domain | RRM_dom_euk | 2.44e-04 | 23 | 100 | 3 | IPR003954 | |
| Domain | P-loop_NTPase | MPP2 DNAH3 SPG7 DHX37 DAPK1 CHD9 TEP1 DHX8 DNAH1 GNAT1 DNAH6 DYNC1H1 DNAH11 | 5.85e-04 | 848 | 100 | 13 | IPR027417 |
| Domain | - | MPP2 DNAH3 SPG7 DHX37 CHD9 TEP1 DHX8 DNAH1 GNAT1 DNAH6 DYNC1H1 DNAH11 | 6.33e-04 | 746 | 100 | 12 | 3.40.50.300 |
| Domain | Kinase-like_dom | CDC42BPA MARK1 DDR2 DAPK1 CHD9 TRRAP CDC42BPB CSNK1A1L DST EPHA4 | 6.51e-04 | 542 | 100 | 10 | IPR011009 |
| Domain | DHC_N1 | 7.78e-04 | 8 | 100 | 2 | PF08385 | |
| Domain | Dynein_heavy_dom-1 | 7.78e-04 | 8 | 100 | 2 | IPR013594 | |
| Domain | AAA | 1.06e-03 | 144 | 100 | 5 | SM00382 | |
| Domain | AAA+_ATPase | 1.06e-03 | 144 | 100 | 5 | IPR003593 | |
| Domain | Ferric_reduct | 1.81e-03 | 12 | 100 | 2 | PF01794 | |
| Domain | Fe3_Rdtase_TM_dom | 1.81e-03 | 12 | 100 | 2 | IPR013130 | |
| Domain | CNH | 2.48e-03 | 14 | 100 | 2 | SM00036 | |
| Domain | CNH | 2.85e-03 | 15 | 100 | 2 | PF00780 | |
| Domain | CNH | 2.85e-03 | 15 | 100 | 2 | PS50219 | |
| Domain | CNH_dom | 2.85e-03 | 15 | 100 | 2 | IPR001180 | |
| Domain | PBD | 3.24e-03 | 16 | 100 | 2 | SM00285 | |
| Domain | C1_1 | 3.53e-03 | 57 | 100 | 3 | PF00130 | |
| Domain | DUF1605 | 3.66e-03 | 17 | 100 | 2 | IPR011709 | |
| Domain | OB_NTP_bind | 3.66e-03 | 17 | 100 | 2 | PF07717 | |
| Domain | HA2 | 4.11e-03 | 18 | 100 | 2 | SM00847 | |
| Domain | HA2 | 4.11e-03 | 18 | 100 | 2 | PF04408 | |
| Domain | Helicase-assoc_dom | 4.11e-03 | 18 | 100 | 2 | IPR007502 | |
| Domain | ZF_DAG_PE_1 | 4.90e-03 | 64 | 100 | 3 | PS00479 | |
| Domain | ZF_DAG_PE_2 | 4.90e-03 | 64 | 100 | 3 | PS50081 | |
| Domain | CRIB | 5.06e-03 | 20 | 100 | 2 | PS50108 | |
| Domain | C1 | 5.12e-03 | 65 | 100 | 3 | SM00109 | |
| Domain | PE/DAG-bd | 5.34e-03 | 66 | 100 | 3 | IPR002219 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SOD1_TO_RETROGRADE_AXONAL_TRANSPORT | 1.45e-05 | 27 | 79 | 4 | M47755 | |
| Pathway | KEGG_MEDICUS_REFERENCE_RETROGRADE_AXONAL_TRANSPORT | 9.55e-05 | 43 | 79 | 4 | M47669 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_RETROGRADE_AXONAL_TRANSPORT | 1.14e-04 | 45 | 79 | 4 | M47670 | |
| Pathway | BIOCARTA_LIS1_PATHWAY | 1.54e-04 | 19 | 79 | 3 | M22005 | |
| Pubmed | 4.68e-10 | 14 | 106 | 5 | 9373155 | ||
| Pubmed | MPP2 NEDD4L MARK1 TTC21A PABPC4 DAPK1 GABARAPL2 WDR37 CDC42BPB PABPC1 ABLIM1 CSNK1A1L DST UPF2 PABPC3 TRAPPC10 PPP1R18 DNAH6 RPL5 DYNC1H1 DNAH11 | 1.93e-09 | 1431 | 106 | 21 | 37142655 | |
| Pubmed | 2.75e-08 | 3 | 106 | 3 | 21940797 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | CDC42BPA NEDD4L MARK1 DHX37 RBM42 CHD9 ACTL6A TRRAP ADAR DHX8 ZNF512B SULF2 DST UPF2 CCDC86 RPL5 DYNC1H1 | 3.06e-08 | 1082 | 106 | 17 | 38697112 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ESPN CDC42BPA NEDD4L TTC21A CHD9 TEP1 WDR37 SLC30A4 TRRAP CDC42BPB TASOR2 DNAH1 PTPN4 ABLIM1 TLL1 ARHGAP8 MMP16 STEAP1 FBXW11 | 1.15e-07 | 1489 | 106 | 19 | 28611215 |
| Pubmed | HIV- 1 protease inhibits Cap- and poly(A)-dependent translation upon eIF4GI and PABP cleavage. | 2.74e-07 | 5 | 106 | 3 | 19956697 | |
| Pubmed | 2.74e-07 | 5 | 106 | 3 | 33744966 | ||
| Pubmed | 5.47e-07 | 6 | 106 | 3 | 10358005 | ||
| Pubmed | Chromosomal localization of three human poly(A)-binding protein genes and four related pseudogenes. | 9.55e-07 | 7 | 106 | 3 | 10543404 | |
| Pubmed | 9.55e-07 | 7 | 106 | 3 | 9256245 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | DHX37 PABPC4 GABARAPL2 ADAR PABPC1 DHX8 ABLIM1 DST PPP1R18 RPL22L1 BCAR3 CCDC86 RPL5 DYNC1H1 | 1.19e-06 | 949 | 106 | 14 | 36574265 |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | ACTL6A WDR37 PABPC1 ABLIM1 CSNK1A1L GLG1 PABPC3 ATG12 TCEANC2 PPP1R18 RPL5 WDR48 | 1.60e-06 | 701 | 106 | 12 | 30196744 |
| Pubmed | 1.96e-06 | 272 | 106 | 8 | 31010829 | ||
| Pubmed | Genome-wide association scan for survival on dialysis in African-Americans with type 2 diabetes. | 2.74e-06 | 32 | 106 | 4 | 21546767 | |
| Pubmed | DHX37 PABPC4 TRRAP PABPC1 TASOR2 DHX8 DST CCDC86 RPL5 DYNC1H1 USP47 | 5.21e-06 | 653 | 106 | 11 | 22586326 | |
| Pubmed | HIVEP1 NACC1 PABPC4 CHD9 GABARAPL2 ACTL6A MED13L PPAT TRRAP ADAR PABPC1 RPL5 DYNC1H1 RASGRP2 | 6.73e-06 | 1103 | 106 | 14 | 34189442 | |
| Pubmed | HIVEP1 CDC42BPA NACC1 DHX37 PABPC4 ACTL6A TRRAP PABPC1 TFE3 ZNF512B DST PABPC3 IRF2BPL CCDC86 DYNC1H1 WDR48 | 6.85e-06 | 1429 | 106 | 16 | 35140242 | |
| Pubmed | A systems-wide screen identifies substrates of the SCFβTrCP ubiquitin ligase. | 7.47e-06 | 232 | 106 | 7 | 25515538 | |
| Pubmed | 8.49e-06 | 332 | 106 | 8 | 37433992 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19020299 | ||
| Pubmed | Cloning and chromosomal localization of human Cdc42-binding protein kinase beta. | 9.20e-06 | 2 | 106 | 2 | 10198171 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26971890 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 36724555 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 37209327 | ||
| Pubmed | Levels of free PABP are limited by newly polyadenylated mRNA in early Spisula embryogenesis. | 9.20e-06 | 2 | 106 | 2 | 10954604 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24360805 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10534404 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 9732454 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12093815 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18263588 | ||
| Pubmed | Transducin activation state controls its light-dependent translocation in rod photoreceptors. | 9.20e-06 | 2 | 106 | 2 | 16207703 | |
| Pubmed | Nucleotide sequence of a mouse testis poly(A) binding protein cDNA. | 9.20e-06 | 2 | 106 | 2 | 1630930 | |
| Pubmed | Developmental expression of poly(A) binding protein mRNAs during spermatogenesis in the mouse. | 9.20e-06 | 2 | 106 | 2 | 7893484 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21612657 | ||
| Pubmed | Dystonin deficiency reduces taste buds and fungiform papillae in the anterior part of the tongue. | 9.20e-06 | 2 | 106 | 2 | 17156752 | |
| Pubmed | NEDD4L DHX37 PABPC4 GABARAPL2 TRRAP ADAR CDC42BPB PABPC1 GPR180 DST GLG1 DIAPH3 CCDC86 CTSZ DYNC1H1 | 9.33e-06 | 1297 | 106 | 15 | 33545068 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | DNAH3 PABPC4 ACTL6A PPAT ADAR PABPC1 UPF2 GOLPH3L PABPC3 DNAH6 RPL5 DYNC1H1 | 1.09e-05 | 847 | 106 | 12 | 35235311 |
| Pubmed | CDC42BPA DHX37 PABPC4 ACTL6A TRRAP ADAR PABPC1 DHX8 ZNF512B IRF2BPL CCDC86 RPL5 | 1.09e-05 | 847 | 106 | 12 | 35850772 | |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | DHX37 PABPC4 ADAR CDC42BPB PABPC1 DHX8 UPF2 RPL22L1 DIAPH3 RPL5 WDR48 | 1.37e-05 | 724 | 106 | 11 | 36232890 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NEDD4L PABPC4 TRRAP ADAR PABPC1 DHX8 ZNF512B ABLIM1 DST RPAP1 CCDC86 RPL5 DYNC1H1 | 1.47e-05 | 1024 | 106 | 13 | 24711643 |
| Pubmed | DNA damage shifts circadian clock time via Hausp-dependent Cry1 stabilization. | 1.68e-05 | 175 | 106 | 6 | 25756610 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | NEDD4L NACC1 PABPC4 PABPC1 TFE3 FANCG ABLIM1 RPAP1 UPF2 ATG12 DIAPH3 RPL5 USP47 | 1.70e-05 | 1038 | 106 | 13 | 26673895 |
| Pubmed | 2.44e-05 | 187 | 106 | 6 | 26460568 | ||
| Pubmed | CDC42BPA PABPC4 CHD9 ACTL6A MED13L PABPC1 DHX8 DNAH1 ABLIM1 DHPS TRAPPC10 RPL5 DYNC1H1 FBXW11 | 2.64e-05 | 1247 | 106 | 14 | 27684187 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 22887640 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 26134869 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 11328870 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 25034140 | ||
| Pubmed | Epab is dispensable for mouse spermatogenesis and male fertility. | 2.76e-05 | 3 | 106 | 2 | 24599567 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 30841425 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 11479226 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 29578408 | ||
| Pubmed | SIRT1 Functions as a Negative Regulator of Eukaryotic Poly(A)RNA Transport. | 2.76e-05 | 3 | 106 | 2 | 28756945 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 26843391 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23589491 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 29701755 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 28635594 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19196137 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 33784440 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 10767089 | ||
| Pubmed | The mouse Y-box protein, MSY2, is associated with a kinase on non-polysomal mouse testicular mRNAs. | 2.76e-05 | 3 | 106 | 2 | 10076007 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 39260747 | ||
| Pubmed | Epab and Pabpc1 are differentially expressed in the postnatal mouse ovaries. | 2.76e-05 | 3 | 106 | 2 | 25370180 | |
| Pubmed | The Na+/Ca2+, K+ exchanger NCKX4 is required for efficient cone-mediated vision. | 2.76e-05 | 3 | 106 | 2 | 28650316 | |
| Pubmed | Epab and Pabpc1 are differentially expressed during male germ cell development. | 2.76e-05 | 3 | 106 | 2 | 22814100 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 28611064 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 37665675 | ||
| Pubmed | De novo variants in the PABP domain of PABPC1 lead to developmental delay. | 2.76e-05 | 3 | 106 | 2 | 35511136 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | DHX37 PABPC4 ACTL6A ADAR PABPC1 TASOR2 DHX8 ABLIM1 DST UPF2 PPP1R18 RPL22L1 RPL5 DYNC1H1 | 2.88e-05 | 1257 | 106 | 14 | 36526897 |
| Pubmed | NACC1 CHD9 ZKSCAN2 ACTL6A TEP1 WDR37 TRRAP ZNF512B SULF2 DHPS ADAM17 PDZRN3 WDR48 | 3.59e-05 | 1116 | 106 | 13 | 31753913 | |
| Pubmed | MPP2 NEDD4L NACC1 DAPK1 CDC42BPB PABPC1 ABLIM1 CSNK1A1L DST PABPC3 DYNC1H1 EPHA4 | 3.84e-05 | 963 | 106 | 12 | 28671696 | |
| Pubmed | Substrate trapping proteomics reveals targets of the βTrCP2/FBXW11 ubiquitin ligase. | 4.70e-05 | 128 | 106 | 5 | 25332235 | |
| Pubmed | The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1. | 4.91e-05 | 212 | 106 | 6 | 33853758 | |
| Pubmed | 5.32e-05 | 24 | 106 | 3 | 25157170 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 16804161 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 28252024 | ||
| Pubmed | Molecular motors: the driving force behind mammalian left-right development. | 5.50e-05 | 4 | 106 | 2 | 10652513 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 15630085 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 20603337 | ||
| Pubmed | A tripartite complex containing MRCK modulates lamellar actomyosin retrograde flow. | 5.50e-05 | 4 | 106 | 2 | 18854160 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 18490513 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 15314026 | ||
| Pubmed | Stress granules inhibit apoptosis by reducing reactive oxygen species production. | 5.50e-05 | 4 | 106 | 2 | 23230274 | |
| Pubmed | Transthyretin Upregulates Long Non-Coding RNA MEG3 by Affecting PABPC1 in Diabetic Retinopathy. | 5.50e-05 | 4 | 106 | 2 | 31847264 | |
| Pubmed | Mutations in dynein genes in patients affected by isolated non-syndromic asthenozoospermia. | 5.50e-05 | 4 | 106 | 2 | 18492703 | |
| Pubmed | R9AP, a membrane anchor for the photoreceptor GTPase accelerating protein, RGS9-1. | 5.50e-05 | 4 | 106 | 2 | 12119397 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 9883581 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 9418861 | ||
| Pubmed | Immunoaffinity enrichment and mass spectrometry analysis of protein methylation. | 5.50e-05 | 4 | 106 | 2 | 24129315 | |
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 28910620 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 22956915 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 19328788 | ||
| Pubmed | 5.50e-05 | 4 | 106 | 2 | 11175280 | ||
| Pubmed | 6.83e-05 | 225 | 106 | 6 | 12168954 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 16609065 | ||
| Pubmed | Interaction of HuDA and PABP at 5'UTR of mouse insulin2 regulates insulin biosynthesis. | 9.15e-05 | 5 | 106 | 2 | 29590218 | |
| Pubmed | Poly(A) tail length regulates PABPC1 expression to tune translation in the heart. | 9.15e-05 | 5 | 106 | 2 | 28653618 | |
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 39056782 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 26492470 | ||
| Pubmed | 9.15e-05 | 5 | 106 | 2 | 12723973 | ||
| Interaction | FBXW11 interactions | HIVEP1 PABPC4 DAPK1 PPAT ADAR PABPC1 TFE3 ATG12 LPIN2 RPL5 DYNC1H1 USP47 FBXW11 | 9.76e-07 | 473 | 104 | 13 | int:FBXW11 |
| Interaction | YWHAB interactions | HIVEP1 CDC42BPA NEDD4L MARK1 PABPC4 DAPK1 WDR37 TRRAP TFE3 PTPN4 ABLIM1 DST TRAPPC10 PRMT9 DYNC1H1 USP47 FBXW11 | 1.63e-05 | 1014 | 104 | 17 | int:YWHAB |
| Cytoband | 16q12.2 | 3.08e-05 | 26 | 107 | 3 | 16q12.2 | |
| GeneFamily | Dyneins, axonemal | 5.91e-07 | 17 | 74 | 4 | 536 | |
| GeneFamily | Proteases, serine|STEAP family | 1.64e-04 | 5 | 74 | 2 | 1324 | |
| GeneFamily | DEAH-box helicases | 1.91e-03 | 16 | 74 | 2 | 500 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP1 CDC42BPA DDR2 DAPK1 CHD9 MED13L WDR37 TRRAP JARID2 PTPN4 DST UPF2 ADAM17 BCAR3 SETD3 EPHA4 FBXW11 | 5.19e-08 | 856 | 105 | 17 | M4500 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | HIVEP1 CDC42BPA DAPK1 CHD9 MED13L TRRAP JARID2 DST UPF2 BCAR3 EPHA4 FBXW11 | 3.79e-07 | 466 | 105 | 12 | M13522 |
| Coexpression | GSE360_L_MAJOR_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.32e-06 | 197 | 105 | 8 | M5210 | |
| Coexpression | GSE40493_BCL6_KO_VS_WT_TREG_UP | 7.42e-06 | 177 | 105 | 7 | M9401 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_4H_BMDC_DN | 1.64e-05 | 200 | 105 | 7 | M3942 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.17e-07 | 198 | 107 | 7 | a9afedbc0556faf4a46f7bf28f4a9adb3bc859d8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 5.17e-07 | 198 | 107 | 7 | 7b5350768f306ec528e271d2ac4470bf668ec6f0 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma|TCGA-Brain / Sample_Type by Project: Shred V9 | 4.43e-06 | 177 | 107 | 6 | e8ab340b20cd41554c3841fe980e078e878af35f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.20e-06 | 182 | 107 | 6 | 5e1b316599436740f1b30875f0ebd33c3edfb2b6 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 5.36e-06 | 183 | 107 | 6 | cfae90c309622b5d499e62a3a8a8b9746478d28d | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-06 | 185 | 107 | 6 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 5.71e-06 | 185 | 107 | 6 | 85cb81759589a26d83676cffbf2bc37399683c10 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-06 | 185 | 107 | 6 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.71e-06 | 185 | 107 | 6 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.89e-06 | 186 | 107 | 6 | 5c4ffe4e4d5536ae9f8794277fe032c693e7dd56 | |
| ToppCell | Ciliated-cil-3|World / Class top | 7.06e-06 | 192 | 107 | 6 | 4989ebb8812b8af1870599acd932849122c05a29 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.27e-06 | 193 | 107 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | (5)_Fibroblast-C_(Myofibroblast)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 7.49e-06 | 194 | 107 | 6 | 29a72e565c19407bbd198cfbc2a78106fe830d05 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 196 | 107 | 6 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 196 | 107 | 6 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 | |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 196 | 107 | 6 | 787c6cd92035e0b1108c2c086c42a229016e476b | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.94e-06 | 196 | 107 | 6 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.41e-06 | 198 | 107 | 6 | 58d805e827299292750b09c6283fdbe406b75f79 | |
| ToppCell | COVID-19_Moderate|World / disease group, cell group and cell class | 8.66e-06 | 199 | 107 | 6 | 952fac67588ad5676f5939e3c7f8bac803c27064 | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.91e-06 | 200 | 107 | 6 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 154 | 107 | 5 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.53e-05 | 154 | 107 | 5 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_T_CD4-Teffector/EM_CD4|GI_large-bowel / Manually curated celltypes from each tissue | 3.76e-05 | 156 | 107 | 5 | 01f2c0c6a936dfb59bc727feef428a906ad2a80b | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells-pDC|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.24e-05 | 160 | 107 | 5 | dee756a2dc9725520d439e7273c489c2284015d8 | |
| ToppCell | ICU-NoSEP-Lymphocyte-T_NK-MAIT|ICU-NoSEP / Disease, Lineage and Cell Type | 5.05e-05 | 166 | 107 | 5 | d3fa2e42497201f1ca57f4f977fbaa0def950033 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.50e-05 | 169 | 107 | 5 | fba841664939c771881ba97f14ef1df6635c04ff | |
| ToppCell | Control-Epithelial_cells-AT1|Control / group, cell type (main and fine annotations) | 6.31e-05 | 174 | 107 | 5 | 548d7f2b958a2bfd2c95eb049ceaab55a559c77d | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l28|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.49e-05 | 175 | 107 | 5 | aa168aeb9ad71aa6c0c28a0657c9eb92a0b28183 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.66e-05 | 176 | 107 | 5 | 852d3da0907fe87c0ef23d75a63ce07619cf0c54 | |
| ToppCell | facs-Aorta|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.66e-05 | 176 | 107 | 5 | 0b3491451be02c18a16cdb875645be47eb867a7f | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.66e-05 | 176 | 107 | 5 | 327a3e81b724252e36d786de92a3ffd721ea6d7b | |
| ToppCell | LPS-IL1RA-Myeloid-Dendritic_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.66e-05 | 176 | 107 | 5 | f3bbe8c1a8d132705eac360cf531261271d84588 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.66e-05 | 176 | 107 | 5 | d2df1e435996c51213e88270af9f928e9e09a6f5 | |
| ToppCell | Ciliated_cells-A-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 7.03e-05 | 178 | 107 | 5 | 255473ee6df8a13079fb3bb61038162a40cb4c2c | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.03e-05 | 178 | 107 | 5 | 3b12db04006db6e94fc45649a4b3a63b92f21a61 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.22e-05 | 179 | 107 | 5 | b35a7f8115c997c390201da01d7cb10b10769aec | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.41e-05 | 180 | 107 | 5 | dcef253f2e97e4436b1b04e8a06a53ff6e64522c | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.41e-05 | 180 | 107 | 5 | 137fc14859c89e1ecd98bee388bb58c04b835847 | |
| ToppCell | 390C-Fibroblasts-Fibroblast-G-|390C / Donor, Lineage, Cell class and subclass (all cells) | 7.41e-05 | 180 | 107 | 5 | cd6790de050151fedfa2c5ea6ad58b72665414b2 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.61e-05 | 181 | 107 | 5 | 6a6bd8e020cb0929b6ecdcb55d467ad24fecfaf0 | |
| ToppCell | LPS_only-Lymphocytic_NKT-T_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.61e-05 | 181 | 107 | 5 | a4347ae554e6dcf03c7001a2b69332b377c7c034 | |
| ToppCell | Calu_3-infected|Calu_3 / Cell line, Condition and Strain | 8.01e-05 | 183 | 107 | 5 | 8f7f5000645f24f20a8d7700c4df1f8953a1780b | |
| ToppCell | COVID-19-Heart-EC_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 8.01e-05 | 183 | 107 | 5 | ff95382cfed592190d0636d2b750328471f82e0d | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.22e-05 | 184 | 107 | 5 | 9cc5c588f7c6631b3fb8a522214a09ca32947e72 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|World / Disease state, Lineage and Cell class | 8.22e-05 | 184 | 107 | 5 | 7fd0b227c3750ffb80e41e92c60fcce46656be14 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 8.22e-05 | 184 | 107 | 5 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4-Exc_L4-5_RORB_RPL31P31|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.43e-05 | 185 | 107 | 5 | a1b2525da018abe458908cab7268bd403ee98d92 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 8.87e-05 | 187 | 107 | 5 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | metastatic_Lymph_Node-B_lymphocytes-Undetermined|metastatic_Lymph_Node / Location, Cell class and cell subclass | 9.09e-05 | 188 | 107 | 5 | 0ddc5dbe2fd905fee20c33d9845629e259faacd9 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.32e-05 | 189 | 107 | 5 | 98f517af255ef234eefc3ed7e6c1d63331ab8af0 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 189 | 107 | 5 | f0a2d4ef9896d764971ebbc6952510c128bb76e8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 189 | 107 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.32e-05 | 189 | 107 | 5 | f7e9b6e6a4de297b660a5b6c9a62f860c147185e | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Control / Disease state, Lineage and Cell class | 9.32e-05 | 189 | 107 | 5 | 937e876122bc4b94372a4104e9c1a9068c232018 | |
| ToppCell | droplet-Lung-LUNG-1m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 189 | 107 | 5 | 378f26f751ab4b470948c35dd8347de72dd12ff7 | |
| ToppCell | renal_medulla_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.32e-05 | 189 | 107 | 5 | 830d9cd0dd706bce22eb2416f07b2c31c870a05a | |
| ToppCell | IPF-Myeloid-Macrophage_Alveolar|IPF / Disease state, Lineage and Cell class | 9.56e-05 | 190 | 107 | 5 | e539ebc0f4c5ee5dba86c614387be7d91338ad47 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|COPD / Disease state, Lineage and Cell class | 9.56e-05 | 190 | 107 | 5 | 006e31606d637033bc81333816ee332773d36b08 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D175|Adult / Lineage, Cell type, age group and donor | 9.56e-05 | 190 | 107 | 5 | 7dcca3469f3a3b70db0420cb94f7765f39492f06 | |
| ToppCell | COPD-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 9.56e-05 | 190 | 107 | 5 | 9fc763d65470ba8858b973689c4d4358faab7dd3 | |
| ToppCell | Myeloid-Myeloid-B_(Activated_Macrophage)|Myeloid / shred on cell class and cell subclass (v4) | 9.80e-05 | 191 | 107 | 5 | 7bf125249af1e8bb138ed4d999fdd74b03ab2447 | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.80e-05 | 191 | 107 | 5 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 9.80e-05 | 191 | 107 | 5 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | Control-Myeloid-Macrophage_Alveolar|Myeloid / Disease state, Lineage and Cell class | 9.80e-05 | 191 | 107 | 5 | a7bb8aba9c59c037d995a77928cc7b4d5cbb82b9 | |
| ToppCell | T_cells-Central_memory_CD4+_T_cells|T_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 9.80e-05 | 191 | 107 | 5 | 25dd538d6a361bd3367c8a1c0dfc9e7003061af3 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.00e-04 | 192 | 107 | 5 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.00e-04 | 192 | 107 | 5 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.00e-04 | 192 | 107 | 5 | e0f4e4470a71bfa81d9dcd8594e5f82aafc24f81 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 1.00e-04 | 192 | 107 | 5 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | COPD-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 1.00e-04 | 192 | 107 | 5 | 62904f94dfce430456f05066522cbf9bd29f4d7e | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 193 | 107 | 5 | ebd090d7801480b3cee45caac3d30cc991836769 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_2_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.03e-04 | 193 | 107 | 5 | 9ab47b360bee1d4f1092c2269e58acebe9584021 | |
| ToppCell | Mild_COVID-19|World / Disease group,lineage and cell class (2021.01.30) | 1.03e-04 | 193 | 107 | 5 | 325b0768827bf8701bfb7f686bb11fd8b1a41a5c | |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 193 | 107 | 5 | 573ad2f848bede1fe20c7b4b352a9242ec294725 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.05e-04 | 194 | 107 | 5 | 3cd90d01ed5a5ce65aad8284dab2537ec16e3d7c | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.05e-04 | 194 | 107 | 5 | 71d3c7448b1734de54187f902f65649f9283bd4c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.05e-04 | 194 | 107 | 5 | 439d3f17c1f4736122b330e98add9292c7036a8e | |
| ToppCell | PBMC-Mild|PBMC / Compartment, Disease Groups and Clusters | 1.05e-04 | 194 | 107 | 5 | d1366b169d14011194e61d16b6b0953349febc78 | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-B_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.08e-04 | 195 | 107 | 5 | 8f5dfcdaccb0c8318f90a33519a8d6d98ba22943 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.08e-04 | 195 | 107 | 5 | db4270c135c392ed443670981656e3cd5b95939d | |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | 1.11e-04 | 196 | 107 | 5 | af4cdc61830685a888a1209826c23bcf54a43084 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 196 | 107 | 5 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | 1.11e-04 | 196 | 107 | 5 | 6d02d494196e3f857d53eea46d9419690d43beca | |
| ToppCell | Mild-CD4+_T_activated|World / Disease group and Cell class | 1.11e-04 | 196 | 107 | 5 | 417b4fc2e4388f34c410576131b02936f93e46b6 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.11e-04 | 196 | 107 | 5 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.13e-04 | 197 | 107 | 5 | fdb92985f7df0c280b87d3e43c2394e70786a2c7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.13e-04 | 197 | 107 | 5 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | wk_20-22-Epithelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 1.13e-04 | 197 | 107 | 5 | 468071c1911cdf8e8806a78dbceb95379e28ae91 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.13e-04 | 197 | 107 | 5 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 1.16e-04 | 198 | 107 | 5 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.16e-04 | 198 | 107 | 5 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | B_cells-Activate_B_cells|B_cells / Immune cells in Kidney/Urine in Lupus Nephritis | 1.16e-04 | 198 | 107 | 5 | a663082d7fbd6db11d3d3024bbb8ba00183e19f8 | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic|LPS_only / Treatment groups by lineage, cell group, cell type | 1.16e-04 | 198 | 107 | 5 | e4e362dca57adba90a2be38dce810857baa2f265 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.16e-04 | 198 | 107 | 5 | d1827e3707b929e3a3562989a0c11537d344e164 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.19e-04 | 199 | 107 | 5 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | (5)_Fibroblast-G|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.19e-04 | 199 | 107 | 5 | b4a737575be9f8c65771832dd8cd25328d5dae0d | |
| ToppCell | LPS_only-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_only / Treatment groups by lineage, cell group, cell type | 1.19e-04 | 199 | 107 | 5 | bd7f03bef4660c347da5f16db34d91d563908448 | |
| ToppCell | LPS_IL1RA_TNF-Hematopoietic_Lymphocytic-Lymphocytic_NK/T-T-cells|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 1.19e-04 | 199 | 107 | 5 | 46e2d2962cd5b0f76baf976c0f6ecce117827274 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.19e-04 | 199 | 107 | 5 | 0902b08e3386e64d7347c186d9ce5b67f2deaabb | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.19e-04 | 199 | 107 | 5 | e1f1950d6f840485e263b83dc81b98910be3ae7a | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 1.20e-06 | 171 | 104 | 8 | 7535_DN | |
| Disease | Global developmental delay | 1.16e-04 | 133 | 105 | 5 | C0557874 | |
| Disease | Large cell carcinoma of lung | 2.01e-04 | 32 | 105 | 3 | C0345958 | |
| Disease | Abnormality of the eye | 2.60e-04 | 7 | 105 | 2 | C4316870 | |
| Disease | Autoinflammatory disorder | 2.64e-04 | 35 | 105 | 3 | C3860213 | |
| Disease | cerebrospinal fluid clusterin measurement | 2.64e-04 | 35 | 105 | 3 | EFO_0007657 | |
| Disease | AUTISM, SUSCEPTIBILITY TO, 15 | 3.46e-04 | 8 | 105 | 2 | C2677504 | |
| Disease | Spastic Paraplegia | 4.44e-04 | 9 | 105 | 2 | C0037772 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 6.76e-04 | 11 | 105 | 2 | DOID:0060669 (implicated_via_orthology) | |
| Disease | hair colour measurement, hair morphology measurement | 8.09e-04 | 12 | 105 | 2 | EFO_0007821, EFO_0007822 | |
| Disease | Intellectual Disability | 1.11e-03 | 447 | 105 | 7 | C3714756 | |
| Disease | cutaneous melanoma, hair color | 1.42e-03 | 62 | 105 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | non-word reading | 1.78e-03 | 67 | 105 | 3 | EFO_0005299 | |
| Disease | thyroid peroxidase antibody measurement | 2.19e-03 | 72 | 105 | 3 | EFO_0005666 | |
| Disease | blood aluminium measurement | 2.29e-03 | 20 | 105 | 2 | EFO_0007575 | |
| Disease | Ovarian Serous Adenocarcinoma | 3.02e-03 | 23 | 105 | 2 | C1335177 | |
| Disease | Cleft Palate | 3.05e-03 | 81 | 105 | 3 | C0008925 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KKRMTIQDSLQHPWI | 261 | P53355 | |
| DPSWRKRMLLTLKSN | 526 | Q76B58 | |
| KPLRTSWQRKMKERQ | 261 | Q9H6F5 | |
| MLQRPKSDKLWSIII | 646 | Q6P2P2 | |
| MADRINIKRKGAWPS | 101 | Q9UBR2 | |
| DRLPLWRRNDMKKKA | 761 | O14639 | |
| MPQITRLEKTWTALR | 656 | O75815 | |
| LMSEAPWNTRAKREK | 121 | O96019 | |
| PWNTRAKREKLTELM | 126 | O96019 | |
| QTMARKNEWPLDKTR | 4391 | Q96DT5 | |
| KPEISMRRLNWLKIR | 641 | Q9NSV4 | |
| RIERTLKSKVMEWRP | 1316 | Q6DHV5 | |
| PIMKTKKWAVERTRT | 66 | O94817 | |
| SKRVLPDTWRNRKLM | 51 | Q8NFF2 | |
| EPRMEWKVKIRSDGT | 916 | Q9UPQ7 | |
| PIKLRKSMWKDRNLD | 451 | Q9BTD8 | |
| KLVEIPTKMRVERWA | 286 | O75916 | |
| KPLARKLMDWEVVSR | 361 | P29074 | |
| RKMLTPRIELSVWKD | 111 | Q8IXQ6 | |
| VIKGKPVRIMWSQRD | 76 | P11940 | |
| MDWKEVLRRRLATPN | 1 | Q969Q6 | |
| MDDKEPKRWPTLRDR | 1 | Q5JPF3 | |
| ADLTKKNRLPVMVWI | 126 | Q9UKY3 | |
| VIKGKPIRIMWSQRD | 76 | Q13310 | |
| RKVWDLKMRDPKSRL | 221 | Q96JB6 | |
| ILTQWDRSLKPMQTR | 486 | P31513 | |
| KMSDPATRKLIEEWQ | 226 | Q71F56 | |
| WLDPARTRLNGAKMK | 321 | Q7LDG7 | |
| PKEMSDIIQRLWKDS | 116 | P11488 | |
| KLMLSCWRRDTKNRP | 826 | Q16832 | |
| EAPRWKQMLTEIDSK | 4591 | Q03001 | |
| MPAWRRDLLRKKLEE | 786 | B1AK53 | |
| LMLDCWQKERSDRPK | 856 | P54764 | |
| TMQKARRKQWDEPRV | 361 | P55107 | |
| LRNRAEEWASKPKMV | 361 | Q9H1B7 | |
| EEWASKPKMVRDTLL | 366 | Q9H1B7 | |
| MIKAWQVPDVEKRRR | 191 | Q96BY2 | |
| ATEAPRMEWKVKVRS | 616 | Q76G19 | |
| KLIERMVRTDPLWKG | 166 | Q9UKB1 | |
| WKRLSRLMSKVNPEP | 441 | Q6X4W1 | |
| GRRSLKNKLIMWDPD | 386 | Q14168 | |
| SLLPKMSRLWEDARK | 426 | O15287 | |
| RTSLPWQGLRAMTKK | 216 | Q8N752 | |
| WTIVRMKKSQSRPLQ | 266 | Q86V85 | |
| PLWKVRRSQKLDMSA | 861 | Q9Y5S2 | |
| QKLWRSLKMLPERGQ | 201 | Q96JZ2 | |
| VIKGKPVRIMWSQRD | 76 | Q9H361 | |
| AREWKGETPRNKLMR | 101 | Q9NUU6 | |
| KPTWLERAKEATISM | 1221 | Q9UHC9 | |
| LSKIKQWALSTPRMR | 411 | Q9P2D7 | |
| PVESKRYQTMERIWK | 1261 | Q9P2D7 | |
| PECKKRLNDRIEMWS | 1106 | Q92896 | |
| PKMAAKIERQQRWTR | 1826 | Q3L8U1 | |
| KSWKEIMRKVNRLPN | 1136 | Q9C0G6 | |
| RPVKHKWTMISRDNN | 466 | Q6WRI0 | |
| PIWHLTDKKRERMQI | 351 | P55265 | |
| RWDRKTMQIGESLPK | 4026 | Q8TD57 | |
| WTPSKMIARLGKEIN | 201 | P49366 | |
| KDTKMSFQWRIRNLP | 96 | Q9BVM2 | |
| WVNDPQRMDKRTLAL | 211 | Q9H4A5 | |
| PIKRGSLEQIMKDRW | 296 | Q9P0L2 | |
| KREENLKMVWRINPA | 441 | Q14204 | |
| LSKRKEPQWGMKERA | 4796 | Q8NDH2 | |
| PMTLSPRWKSVLKDV | 1006 | A6NE01 | |
| MLKTWARLQPRTESL | 1091 | Q8IY37 | |
| EKAERERLSQMPAWK | 26 | Q6NYC8 | |
| LTRISDPEKWEIKQM | 391 | Q14562 | |
| MWIIRKRIQLPSEKA | 61 | P60520 | |
| VTTEKVLRQMRKLPW | 786 | Q9HAU5 | |
| KWNKLADMLRIPRTA | 676 | Q92833 | |
| ARRRLKKENKMTWAP | 181 | P78415 | |
| KKENKMTWAPRSRTD | 186 | P78415 | |
| DIKRWKTMLELPDQT | 41 | Q96MN5 | |
| KPEDIRSTSNTLWMK | 541 | O43897 | |
| LWVPRKLLMTVESAK | 121 | Q86TU7 | |
| WNRPKMSLAQKKDRV | 266 | P46777 | |
| KMIAPQRWIDAQREK | 756 | Q9UQ90 | |
| NSMEWIQTLPLKKVR | 1476 | Q5VT25 | |
| DITNQEELWKMKPRR | 6 | Q9UHE8 | |
| DITNQEEIWKMKPRR | 6 | Q6NZ63 | |
| PLWRFVNDTKDKRML | 151 | P78536 | |
| MRRPWEKKEATRNPI | 1 | Q5SY13 | |
| LWRMIAELKERSQRP | 241 | Q6AZZ1 | |
| AELKERSQRPVRWML | 246 | Q6AZZ1 | |
| EERVSKPLLWGRMNK | 386 | Q70EL2 | |
| VLRVWDPRTCAKLMK | 191 | Q8TAF3 | |
| MAPQKDRKPKRSTWR | 1 | Q6P5R6 | |
| AGKRMKLSRPETWER | 486 | Q99973 | |
| ASKDRDVKLWERPSM | 2571 | Q99973 | |
| GKVDRNTIDWMKKPR | 86 | P51512 | |
| TVPKMLRDVWSEEKL | 81 | P0C645 | |
| SSDPEMRWNKGTILK | 376 | P19532 | |
| TAVKSRQPLWGLKEM | 1111 | Q9UJ98 | |
| REKPGDWKMQSRKRT | 426 | P42331 | |
| TDMKSKVRQRLIHPW | 71 | A6NCN8 | |
| TPDWVARIKNLMKEA | 166 | Q06203 | |
| AVLSRRWKPSEMKLD | 1226 | Q96K76 | |
| RQTLKLLSRPEMWRA | 776 | Q9BWH6 | |
| RMQLKRLAKTPWVLS | 1181 | Q8NDW8 | |
| MWPRLVSNSKLKRSS | 106 | P85298 | |
| WTKRRMKDDLVPETA | 706 | Q96KM6 | |
| KVWDLKNMRSPIATI | 391 | Q9Y2I8 | |
| AWKRLKSMLRKDDAP | 6 | O14863 | |
| CRWLKPEMRSKEQIL | 71 | Q63HK3 | |
| ERSENVLMSPWKGKL | 11 | Q5VWN6 | |
| VKSWNGLILRKPIDM | 276 | P48553 | |
| DMKTVVKTWRNRLPI | 2966 | Q9Y4A5 | |
| IWEQTPQIRKRRKMK | 1021 | P15822 | |
| QRRKWPEMKRPSSKS | 846 | Q8IWU5 | |
| REKKTSWKNQMEPER | 166 | Q9C030 | |
| WRKRESMTKQLPESK | 561 | Q92539 | |
| NARRVVRKSWMPKVK | 466 | Q96RE7 | |
| MSVKRPDVLKARLWI | 636 | Q96PU5 |